Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-16

Clinical Trial Update: Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing amlodipine plus losartan versus losartan alone in essential hypertension has completed, evaluating the efficacy and safety of the comb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cozaar (losartan)
  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Hypertension | Phase 3 | Status: COMPLETED